American Rheinmetall Wins $710,000 Kongsberg Award for MCT-30 Parts
American Rheinmetall said Kongsberg Defence & Aerospace awarded it a contract worth about $710,000 to produce machined components for the MCT-30 turret. The…
Austrian Post to Offer Verbund Power and Gas Tariffs This Autumn
Austrian Post said it expects to offer exclusive electricity and gas tariffs from Verbund this autumn in about 330 company-operated branches. Further details…
BP Appoints Ian Tyler as Chair, Effective Immediately
BP said its board appointed Ian Tyler as chair of the company, effective immediately. Tyler joined the BP board as a non-executive director…
Shell Agrees to Buy Rest of Tri Star Energy, Adding 320 U.S. Sites
Shell said Equilon Enterprises, doing business as Shell Oil Products US, signed an agreement to raise its stake in Tri Star Energy from…
Nestlé Agrees to Sell Mainstream Vitamins Business for $1 Billion
Nestlé said it agreed to sell its mainstream vitamins, minerals and supplements business to Yellow Wood Partners for $1.0 billion (CHF 0.8 billion).…
UBS Says Swiss Panel Recommendations Would Require $13 Billion Extra AT1
UBS said recommendations from Switzerland’s upper-house economic committee would require parent bank UBS AG to hold about $13 billion of extra Tier 1…
IHG Signs Franchise Deal for 40-Room Garner Hotel in Ahmedabad
IHG Hotels & Resorts said it signed a franchise agreement for Garner Hotel Ahmedabad Motera, a 40-room hotel scheduled to open in 2029.…
Rheinmetall LUNA NG Gets Provisional Airworthiness Certificate From German Military
Rheinmetall said Germany’s Bundeswehr Aviation Authority granted provisional airworthiness certification for its LUNA NG unmanned reconnaissance system. Full type certification is still pending,…
Rheinmetall Delivers First Lynx XM30 Prototype to U.S. Army
American Rheinmetall said it delivered the first of eight Lynx XM30 combat vehicle prototypes to the U.S. Army. The prototype has entered government-led…
AstraZeneca Wins EU Approval for Enhertu Combination in First-Line Breast Cancer
AstraZeneca and Daiichi Sankyo said Enhertu plus pertuzumab was approved in the EU as first-line treatment for adults with unresectable or metastatic HER2-positive…